Has Dean Wang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $78,905 in general payments to Dean Wang, MD across 201 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dean Wang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dean Wang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dean Wang, MD

Sports Medicine · Orange, CANPI 1235438482

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $49,134 of the $78,905 with a category attached, or 62.3%. 18 manufacturers reported payments, led by Medical Device Business Services, Inc. at 33.3% of the total. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,905in general payments, 2019–2025

Across 201 payments — averaging $392.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$26K
Vericel Corporation$9K
Depuy Synthes Products, Inc.$9K
Ipsen Bioscience Inc.$8K
Arthrex$7K
Ranfac Corporation$5K
plus $15K from 12 others

$37,067in research payments, 2019–2025

Across 2 payments — averaging $18,533 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vericel Corporation$30K
Arthrex$7K

$50,393in ownership & investment interests, 2019–2025

Across 1 payment — averaging $50,393 each. An ownership or investment interest held by the physician or an immediate family member.

Overture Orthopaedics$50K

What the payments were for

Consulting fees$49,13462%
Speaking & faculty fees$5,3257%
Travel & lodging$8,72511%
Food & beverage$9,44512%
Education$6,2578%
Entertainment$190%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	27	$26,262
Vericel Corporation	17	$9,066
Depuy Synthes Products, Inc.	4	$8,505
Ipsen Bioscience Inc.	1	$8,400
Arthrex	27	$7,012
Ranfac Corporation	1	$5,057
Stryker	20	$4,002
Johnson & Johnson	67	$3,605
Moximed, Inc	8	$2,890
Saxum Surgical, Inc.	6	$1,624
Micromed Inc	2	$1,318
Overture Orthopaedics	7	$526
Team_makena_llc	6	$262
Medacta USA, Inc.	1	$124
Linvatec Corporation	2	$101
Lifenet Health	1	$52
DJO, LLC	2	$51
Pacira Therapeutics, Inc.	2	$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MACI$8,675
DYSPORT$8,400
MISHA KNEE SYSTEM, SMALL, LEFT$2,817
RIGIDLOOP$1,573
INSIGNIA$1,488
MILAGRO$806
TRUESPAN ORTHOCORD$714
PROCINCH$494
DYNACORD$465
GRYPHON$404
OVERTURETI$401
HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$342
KNOTILUS ANCHOR, 3.5MM$281
ICONIX$252
FMS Duo$239
MONOVISC$214
PIVOT PORTAL ENTRY KIT$189
NANO TACT FLEX$166
TWISTR$124
HEALIX KNOTLESS PEEK$124

How this compares

$78,905 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California →

Medicare billing

Part B allowed, 2024

$60,733

Medicare patients

163

Services billed

388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	21	$250

Paid to pharmacies, not to this prescriber.

Other sports medicine in Orange

Kevin ParvareshOrange$67K
Adam RivadeneyraOrange$58K
Neal ElattracheLos Angeles$51M
Nathaniel CohenLos Gatos$6.4M
Thomas KnappSanta Monica$2.5M
Michael FreehillStanford$1.6M
Allan MishraMenlo Park$1.5M
Heinz Hoeneckela Jolla$1.4M
Seth ShermanStanford$1.1M
Stephan YacoubianBurbank$1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →